Related Experiment Video
Updated: May 8, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
D Allegra1, V Bilan2, A Garding3
11] Department of Internal Medicine III, Ulm University, Ulm, Germany [2] Cooperation Unit 'Mechanisms of Leukemogenesis', German Cancer Research Center DKFZ, Heidelberg, Germany.
Abstract:
The MIR-15A/-16-1 tumor suppressor microRNAs (miRNAs) are deleted in leukemic cells from more than 50% of patients with chronic lymphocytic leukemia (CLL). As these miRNAs are also less abundant in patients without genomic deletion, their downregulation in CLL is likely to be caused by additional mechanisms. We found the primary transcripts (pri-miRNAs) of MIR-15a/-16/-15b to be elevated and processing intermediates (precursor miRNAs) to be reduced in cells from CLL patients (22/38) compared with non-malignant B-cells (n=14), indicating a block of miRNA maturation at the DROSHA processing step. Using a luciferase reporter assay for pri-miR processing we validated the defect in primary CLL cells. The block of miRNA maturation is restricted to specific miRNAs and can be found in the cell line MEC-2, but not in MEC-1, even though both are derived from the same CLL patient. In these cells, the RNA-specific deaminase ADARB1 leads to reduced pri-miRNA processing, but full processing efficiency is recovered upon deletion of the RNA-binding domains or nuclear localization of ADARB1. Thus, we show that, apart from genomic deletion or transcriptional downregulation, aberrant processing of miRNA leads to specific reduction of miRNAs in leukemic cells. This represents a novel oncogenic mechanism in the pathogenesis of CLL.
Insights
The MIR-15A/-16-1 tumor suppressor microRNAs (miRNAs) are downregulated in chronic lymphocytic leukemia (CLL) due to aberrant processing, not just deletion. This novel mechanism involves blocked miRNA maturation, impacting leukemic cell development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The MIR-15A/-16-1 microRNAs (miRNAs) are crucial tumor suppressors frequently deleted in chronic lymphocytic leukemia (CLL).
- Downregulation of these miRNAs in CLL occurs even without genomic deletion, suggesting alternative regulatory mechanisms.
- Understanding these mechanisms is vital for elucidating CLL pathogenesis.
Purpose of the Study:
- To investigate the mechanisms underlying the downregulation of MIR-15A/-16-1 miRNAs in chronic lymphocytic leukemia (CLL).
- To identify novel oncogenic pathways involved in CLL pathogenesis beyond genomic deletion or transcriptional downregulation.
- To explore the role of miRNA processing defects in leukemic cells.
Main Methods:
- Analysis of primary and precursor microRNA (miRNA) levels in CLL patient cells and non-malignant B-cells.
- Luciferase reporter assays to assess pri-miRNA processing efficiency.
- Investigation of miRNA maturation block in CLL cell lines (MEC-1 and MEC-2).
- Functional studies of ADARB1 (RNA-specific deaminase) in miRNA processing.
Main Results:
- Elevated primary miRNA transcripts and reduced precursor miRNAs were observed in CLL cells, indicating a maturation block at the DROSHA processing step.
- The miRNA maturation defect was validated in primary CLL cells using luciferase assays.
- The RNA-specific deaminase ADARB1 was identified as a key factor causing reduced pri-miRNA processing in specific CLL cells (MEC-2).
- Restoration of processing efficiency was achieved by altering ADARB1's RNA-binding domains or nuclear localization.
Conclusions:
- Aberrant miRNA processing, specifically a block in miRNA maturation, represents a novel mechanism contributing to the specific reduction of miRNAs in leukemic cells.
- This processing defect, mediated by factors like ADARB1, plays a significant role in the oncogenesis of chronic lymphocytic leukemia.
- These findings expand the understanding of miRNA regulation in cancer beyond genomic alterations and transcriptional control.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs
MicroRNAs
Abnormal Proliferation
Inflammatory Bowel Disease III: Crohn's Disease

